-
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
(PAR-21-321)
National Cancer Institute
Application Receipt Date(s): January 25, 2022, January 25, 2023, January 25, 2024
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
(PAR-21-341)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
(PAR-22-034)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
(PAR-22-038)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
(PAR-22-039)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
(PAR-22-040)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
(PAR-22-048)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute of Environmental Health Sciences
Application Receipt Date(s): March 11, 2022
-
Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed)
(RFA-AI-21-070)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): February 18, 2022
-
NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)
(RFA-AT-22-001)
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): December 15, 2021
-
Diabetes Research Centers (P30 Clinical Trial Optional)
(RFA-DK-21-029)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 8, 2022
-
Pelvic Floor Disorders Network (UG1 Clinical Trial Required)
(RFA-HD-22-021)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): December 6, 2021
-
Pelvic Floor Disorders Network (U24 Clinical Trial Required)
(RFA-HD-22-022)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): December 6, 2021
-
NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed)
(RFA-NS-21-025)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): November 1, 2021, by 5:00 PM local time of applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Month(s) Day(s), Year(s) orStandard datesapply.
-
Occupational Safety and Health Training Project Grants (T03)
(RFA-OH-22-003)
National Institute for Occupational Safety and Health
Application Receipt Date(s): October 23, 2025